LONA (LeonaBio) Tariff Resilience Score: 9/10 (As of Jul. 06, 2026)


LONA LeonaBio Inc LONA
28 GF Score
Price $8.68
! 2 Warning Signs
View Full Analysis

What is LeonaBio Tariff Resilience Score?

LeonaBio LONA -2.14% 28 Tariff Resilience Score is 9 as of Jul. 06, 2026. GuruFocus rates LONA with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 1,369 Biotechnology companies, LeonaBio ranks better than 99.93% on this metric.

LeonaBio has the Tariff Resilience Score of 9, which implies that the company might have Highly Resilient.

LeonaBio has Athira Pharma Inc is highly resilient to tariffs as its operations are primarily focused on domestic pharmaceutical research and development. The company has minimal exposure to international supply chains and has not been affected by past tariff changes.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes LeonaBio might have Highly Resilient.

LeonaBio  (NAS:LONA) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

LeonaBio Tariff Resilience Score Related Terms

LONA vs ICCC, TELO, PYPD: Tariff Resilience Score Comparison

For the Biotechnology subindustry, LeonaBio's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LeonaBio Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LeonaBio's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where LeonaBio's Tariff Resilience Score falls into.


LONA
28GF Score
LeonaBio Inc LONA
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 9 mean?
LeonaBio (LONA) has a Tariff Resilience Score of 9 as of Jul. 06, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, LeonaBio ranks #1 out of 1369 companies in the Biotechnology industry, placing it in the top 0.099999999999994%.
Is LeonaBio's Tariff Resilience Score too high?
LeonaBio's current Tariff Resilience Score is 9. The Biotechnology industry median Tariff Resilience Score is 4.00. LeonaBio's value of 9 is 125% above this industry median. Based on the distribution chart, LeonaBio ranks #1 out of 1369 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, LeonaBio has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does LeonaBio's Tariff Resilience Score compare to ICCC and TELO?
According to the Biotechnology industry distribution chart, LeonaBio ranks #1 out of 1369 companies for Tariff Resilience Score. This places LeonaBio in the top 0% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. LeonaBio's value of 9 is 125% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,369 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LeonaBio's current Tariff Resilience Score of 9 is 125% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LeonaBio's current Tariff Resilience Score is 9. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeonaBio stock overvalued right now?
LeonaBio (LONA) has a current Tariff Resilience Score of 9. The current Tariff Resilience Score is 9 and 125% above the Biotechnology industry median of 4.00. LeonaBio's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For LeonaBio (LONA), the current Tariff Resilience Score is 9 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LeonaBio Business Description

Address 18706 North Creek Parkway, Suite 104, Bothell, WA, USA, 98011
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
28GF Score

Get the complete analysis for LONA

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.68
Price